153 related articles for article (PubMed ID: 34315625)
1. Reply to Laurence Klotz's Letter to the Editor re: Jeremy Yuen-Chun Teoh, Daniele Castellani, Claudia Mercader, et al. A Quantitative Analysis Investigating the Prevalence of "Manels" in Major Urology Meetings. Eur Urol 2021;80:442-9.
Teoh JY; Murphy DG; van Oort IM; Loeb S; Ribal MJ
Eur Urol; 2021 Oct; 80(4):e101. PubMed ID: 34315625
[No Abstract] [Full Text] [Related]
2. Reply to Laurence Klotz's Letter to the Editor re: Jeremy Yeun-Chun Teoh, Daniele Castellani, Claudia Mercader, et al. A Quantitative Analysis Investigating the Prevalence of "Manels" in Major Urology Meetings. Eur Urol 2021;80:442-9. Eur Urol 2021;80:e100.
Dev S
Eur Urol; 2022 Jan; 81(1):e25. PubMed ID: 34663524
[No Abstract] [Full Text] [Related]
3. Reply to Laurence Klotz's Letter to the Editor re: Jeremy Yeun-Chun Teoh, Daniele Castellani, Claudia Mercader, et al. A Quantitative Analysis Investigating the Prevalence of "Manels" in Major Urology Meetings. Eur Urol 2021;80:442-9. Eur Urol 2021;80:e100: Reply from the European Association of Urology Equity, Diversity, and Inclusion Task Force.
Carmen Mir M; Greenwell T; O'Kelly F; Proietti S; Laukhtina E; Mertens L; Morgenstern S; Ouzaid I;
Eur Urol; 2022 Jan; 81(1):e26-e27. PubMed ID: 34772550
[No Abstract] [Full Text] [Related]
4. Re: Jeremy Yuen-Chun Teoh, Daniele Castellani, Claudia Mercader, et al. A Quantitative Analysis Investigating the Prevalence of "Manels" in Major Urology Meetings. Euro Urol 2021;80:442-9.
Rutka JT; Fleshner N; Nathens AB
Eur Urol; 2022 Feb; 81(2):e51. PubMed ID: 34872785
[No Abstract] [Full Text] [Related]
5. Re: Jeremy Yeun-Chun Teoh, Daniele Castellani, Claudia Mercader, et al. A Quantitative Analysis Investigating the Prevalence of "Manels" in Major Urology Meetings. Eur Urol 2021;80:442-9.
Klotz L
Eur Urol; 2021 Oct; 80(4):e100. PubMed ID: 34399997
[No Abstract] [Full Text] [Related]
6. Reply to Jon Mikel Inarritu, Daniele Castellani, and Jeremy Y.C. Teoh's Letter to the Editor re: Agustina Bessa, Steven Maclennan, Deborah Enting, et al. Consensus in Bladder Cancer Research Priorities Between Patients and Healthcare Professionals Using a Four-stage Modified Delphi Method. Eur Urol 2019;76:260-1.
Bessa A; Maclennan S; Enting D; Bryan R; Häggström C; Van Hemelrijck M
Eur Urol; 2019 Aug; 76(2):e45-e46. PubMed ID: 31109813
[No Abstract] [Full Text] [Related]
7. Reply to Jeremy Y.C. Teoh, Thomas R.W. Herrmann, and Marek Babjuk's Letter to the Editor re: Valeria Panebianco, Yoshifumi Narumi, Ersan Altun, et al. Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting and Data System). Eur Urol 2018;74:294-306.
Panebianco V; Barentsz J; Narumi Y; Catto JWF
Eur Urol; 2019 Feb; 75(2):e29-e30. PubMed ID: 30471881
[No Abstract] [Full Text] [Related]
8. Reply to Yongbao Wei, Ruochen Zhang, and Le Lin's Letter to the Editor re: Börje Ljungberg, Laurence Albiges, Yasmin Abu-Ghanem, et al. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update. Eur Urol. 2022;82:e88.
Ljungberg B; Bedke J; Capitanio U; Bex A
Eur Urol; 2022 Oct; 82(4):e111-e112. PubMed ID: 35773149
[No Abstract] [Full Text] [Related]
9. Reply to Yaxiong Tang, Xu Hu, Kan Wu, Yanxiang Shao, and Xiang Li's Letter to the Editor re: Umberto Capitanio, Jens Bedke, Laurence Albiges, et al. A Renewal of the TNM Staging System for Patients with Renal Cancer To Comply with Current Decision-making: Proposal from the European Association of Urology Guidelines Panel. Eur Urol. 2022;83:3-5.
Capitanio U; Bedke J; Albiges L; Volpe A; Giles RH; Hora M; Marconi L; Klatte T; Abu-Ghanem Y; Dabestani S; Fernández Pello S; Hofmann F; Kuusk T; Campi R; Tahbaz R; Powles T; Ljungberg B; Bex A
Eur Urol; 2023 Mar; 83(3):e74-e75. PubMed ID: 36526491
[No Abstract] [Full Text] [Related]
10. Reply to Liang Sun and Yi Feng's Letter to the Editor re: Malte W. Vetterlein, Jakob Klemm, Philipp Gild, et al. Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of Urology Quality Criteria for Standardized Reporting and Introducing the Comprehensive Complication Index. Eur Urol 2019;77:55-65: Importance of Surgical and Anesthesiological Standard Operating Procedures for Radical Cystectomy in a Bundled Care Setting.
Vetterlein MW; Rink M
Eur Urol; 2020 Jan; 77(1):e12-e13. PubMed ID: 31607396
[No Abstract] [Full Text] [Related]
11. Reply to Anju Murayama's Letter to the Editor re: David-Dan Nguyen, Liam Murad, Anne Xuan-Lan Nguyen, et al. Industry Payments to American Editorial Board Members of Major Urology Journals. Eur Urol. Eur Urol. 2023;84:442-43.
Nguyen DD; Nguyen AV; Murad L; Labban M; Trinh QD; Wallis CJD; Bhojani N
Eur Urol; 2023 Dec; 84(6):e140-e141. PubMed ID: 37770285
[No Abstract] [Full Text] [Related]
12. Reply to Francesco Montorsi, Marco Bandini, and Andrea Necchi's Letter to the Editor re: Malte W. Vetterlein, Jakob Klemm, Philipp Gild, et al. Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of Urology Quality Criteria for Standardized Reporting and Introducing the Comprehensive Complication Index. Eur Urol 2020;77:55-65: Assessing the Morbidity of Multimodal Approaches in Patients with Muscle-invasive Bladder Cancer.
Vetterlein MW; Gild P; Fisch M; Rink M
Eur Urol; 2020 Aug; 78(2):e77-e78. PubMed ID: 32376138
[No Abstract] [Full Text] [Related]
13. Reply to Claudia Signorini and Massimo Maffezzini's Letter to the Editor re: Maria S. Lindgren, Peter Bue, Nessn Azawi, et al. The DaBlaCa-13 Study: Short-term, Intensive Chemoresection Versus Standard Adjuvant Intravesical Instillations in Non-muscle-invasive Bladder Cancer-A Randomized Controlled Trial. Eur Urol 2020;78:856-62.
Lindgren MS; Jensen JB
Eur Urol; 2021 May; 79(5):e137. PubMed ID: 33593653
[No Abstract] [Full Text] [Related]
14. Reply to Valeria Panebianco, Francesco Del Giudice, Yoshifumi Narumi, Giuseppe Simone, Ettore De Berardinis, and James Catto's Letter to the Editor re: Helena Vila-Reyes, G. Joel De Castro, and James M. McKiernan's Letter to the Editor re: Yunjin Bai, Yubo Yang, and Yin Tang's Letter to the Editor re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study. Eur Urol 2020; 77:636-43. Eur Urol 2020;77:e158: Can mpMRI Replace Conventional Transurethral Resection of Bladder Cancer? Eur Urol 2021;79:e35-e36.
Vila-Reyes H; Joel DeCastro G; McKiernan JM
Eur Urol; 2021 Feb; 79(2):e54-e55. PubMed ID: 33248798
[No Abstract] [Full Text] [Related]
15. Reply to Juan Pablo Valdevenito, Marcio Augusto Averbeck, Sanjay Sinha, Enrico Finazzi-Agro, and Andrew Gammie's Letter to the Editor re: Karl H. Pang, Riccardo Campi, Salvador Arlandis, et al. Diagnostic Tests for Female Bladder Outlet Obstruction: A Systematic Review from the European Association of Urology Non-neurogenic Female LUTS Guidelines Panel. Eur Urol Focus 2022;8:1015-30.
Pang KH; Campi R; Imran Omar M; Harding CK
Eur Urol Focus; 2023 Jul; 9(4):629-630. PubMed ID: 36737363
[No Abstract] [Full Text] [Related]
16. Reply to Yan Shibing and Wei Qiang's Letter to the Editor re: Morgan Rouprêt, Marko Babjuk, Eva Compérat, et al. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update. Eur Urol 2015;68:868-79.
Rouprêt M
Eur Urol; 2016 Mar; 69(3):e51-2. PubMed ID: 26461109
[No Abstract] [Full Text] [Related]
17. Reply to Takeshi Takahashi's Letter to the Editor re: Bimal Bhindi, Christine M. Lohse, Phillip J. Schulte, et al. Predicting functional outcomes after partial and radical nephrectomy. Eur Urol 2019;75:766-72. Partial Nephrectomy: "Geocentrism" of the 21st century in the Church of Urology?
Bhindi B; Lohse CM; Schulte PJ; Mason RJ; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2019 Sep; 76(3):e67-e68. PubMed ID: 31167750
[No Abstract] [Full Text] [Related]
18. A Quantitative Analysis Investigating the Prevalence of "Manels" in Major Urology Meetings.
Teoh JY; Castellani D; Mercader C; Sierra A; Heldwein FL; Chan EO; Wroclawski ML; Sepulveda F; Cacciamani GE; Rivas JG; Murphy DG; van Oort IM; Loeb S; Ribal MJ
Eur Urol; 2021 Oct; 80(4):442-449. PubMed ID: 34092439
[TBL] [Abstract][Full Text] [Related]
19. Re: Helena Vila-Reyes, G. Joel DeCastro, and James M. McKiernan's Letter to the Editor re: Yunjin Bai, Yubo Yang, and Yin Tang's Letter to the Editor re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study. Eur Urol 2020; 77:636-43. Eur Urol 2020;77:e158: Can mpMRI Replace Conventional Transurethral Resection of Bladder Cancer? Eur Urol 2021;79:e35-e36.
Panebianco V; Del Giudice F; Narumi Y; Simone G; De Berardinis E; Catto JWF
Eur Urol; 2021 Feb; 79(2):e52-e53. PubMed ID: 33261940
[No Abstract] [Full Text] [Related]
20. Reply to Chen Cheng, Sunxiang Ma, and Yang Liu's Letter to the Editor re: Dan Wood, Andrew Baird, Luca Carmignani, et al. Lifelong Congenital Urology: The Challenges for Patients and Surgeons. Eur Urol 2019;75:1001-7.
Wood D; Baird A; Carmignani L; De Win G; Hoebeke P; Holmdahl G; Manzoni G; Nijman RJM; Taylor C; Tekgul S
Eur Urol; 2019 Oct; 76(4):e94-e95. PubMed ID: 31327638
[No Abstract] [Full Text] [Related]
[Next] [New Search]
